{"id":"rtpa","safety":{"commonSideEffects":[{"rate":"6–7","effect":"Intracranial hemorrhage"},{"rate":"5–10","effect":"Systemic bleeding"},{"rate":null,"effect":"Reperfusion arrhythmias"},{"rate":"0.1–1","effect":"Angioedema"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"rtPA binds to fibrin in thrombi and catalyzes the conversion of plasminogen to plasmin, which degrades the fibrin matrix of blood clots. This mechanism enables rapid clot dissolution in acute thrombotic conditions. rtPA is selective for fibrin-bound plasminogen, which provides some selectivity for clot lysis over systemic fibrinolysis.","oneSentence":"rtPA is a tissue plasminogen activator that converts plasminogen to plasmin, directly dissolving fibrin clots through fibrinolysis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:06:22.899Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute ischemic stroke (within 3–4.5 hours of symptom onset)"},{"name":"Acute myocardial infarction"},{"name":"Pulmonary embolism"}]},"trialDetails":[{"nctId":"NCT07411079","phase":"","title":"Ex Vivo Reproduction of Minimally Invasive Surgery With Hematoma Lysis Using Modified Tissue Plasminogen Activator for Intracerebral Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Lille","startDate":"2026-02","conditions":"Intracerebral Hemorrhage, Hemorrhagic Risk Conditions, Bleeding Disorders","enrollment":1126},{"nctId":"NCT06658197","phase":"PHASE3","title":"Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2025-12-25","conditions":"Stroke, Ischemic, Stroke, Acute, Thrombosis, Brain","enrollment":850},{"nctId":"NCT04356833","phase":"PHASE2","title":"Nebulised Rt-PA for ARDS Due to COVID-19","status":"COMPLETED","sponsor":"University College, London","startDate":"2020-04-22","conditions":"COVID","enrollment":35},{"nctId":"NCT05300672","phase":"PHASE3","title":"Fibrinogen Replacement to Prevent Intracranial Haemorrhage in Ischemic Stroke Patients After Thrombolysis (FibER)","status":"COMPLETED","sponsor":"Azienda Usl di Bologna","startDate":"2022-02-08","conditions":"Intracranial Hemorrhages, Ischemic Stroke","enrollment":207},{"nctId":"NCT06660719","phase":"PHASE3","title":"Efficacy and Safety of SP-8203 (Otaplimastat) in Patients With Acute Ischemic Stroke Receiving Thrombolytic Standard of Care","status":"RECRUITING","sponsor":"Shin Poong Pharmaceutical Co. Ltd.","startDate":"2025-02-14","conditions":"Ischemic Stroke","enrollment":852},{"nctId":"NCT04088292","phase":"PHASE3","title":"Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2019-06-06","conditions":"Pulmonary Embolism","enrollment":210},{"nctId":"NCT06667882","phase":"NA","title":"Safe Delivery of Thrombolytic Treatment for Pulmonary Embolism Using ClotPro® Viscoelastic Tests","status":"COMPLETED","sponsor":"Semmelweis University","startDate":"2021-12-17","conditions":"Pulmonary Embolism Subacute Massive, Complication of Treatment, Fibrinolysis; Hemorrhage","enrollment":33},{"nctId":"NCT06621121","phase":"","title":"A Real-world Study of Tenecteplase Versus Alteplase for Thrombolysis in Patients Within 4.5 H of Onset of Ischemic Stroke","status":"RECRUITING","sponsor":"Tianjin Huanhu Hospital","startDate":"2024-10-26","conditions":"Stroke Acute, Tenecteplase, Alteplase","enrollment":6000},{"nctId":"NCT06374953","phase":"","title":"A Novel Viscoelastic Test Based on Ultrasonic Guided Wave for Identifying Hyperfibrinolysis Rapidly","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2024-03-26","conditions":"Hyperfibrinolysis","enrollment":140},{"nctId":"NCT02814409","phase":"PHASE3","title":"Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis","status":"COMPLETED","sponsor":"NHS Greater Glasgow and Clyde","startDate":"2016-12-15","conditions":"Ischemic Stroke","enrollment":1858},{"nctId":"NCT03417401","phase":"PHASE1","title":"Surgical Stabilizer Assisted RVC With rtPA for CRVO","status":"WITHDRAWN","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2018-10-16","conditions":"Central Retinal Vein Occlusion","enrollment":""},{"nctId":"NCT04479449","phase":"PHASE2","title":"Efficacy and Safety of SP-8203 in Patients With Ischemic Stroke Requiring rtPA","status":"COMPLETED","sponsor":"Shin Poong Pharmaceutical Co. Ltd.","startDate":"2019-03-18","conditions":"Ischemic Stroke","enrollment":178},{"nctId":"NCT05644938","phase":"NA","title":"Optimizing Door-to-reperfusion Times of One-stop Management in Acute Ischemic Stroke","status":"UNKNOWN","sponsor":"Can Tho Stroke International Services Hospital","startDate":"2023-02-01","conditions":"Acute Ischemic Stroke","enrollment":50},{"nctId":"NCT04751708","phase":"NA","title":"Endovascular Treatment for Acute Basilar Artery Occlusion","status":"COMPLETED","sponsor":"The First Affiliated Hospital of University of Science and Technology of China","startDate":"2021-02-21","conditions":"Basilar Artery Occlusion, Acute Cerebrovascular Accident, Stroke Due to Basilar Artery Occlusion","enrollment":340},{"nctId":"NCT03539445","phase":"PHASE3","title":"Efficacy and Safety of Butylphthalide for Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis or Endovascular Treatment","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2018-07-01","conditions":"Acute Ischemic Stroke","enrollment":1216},{"nctId":"NCT03876119","phase":"PHASE2, PHASE3","title":"Intraarterial Alteplase Versus Placebo After Mechanical Thrombectomy","status":"COMPLETED","sponsor":"Hospital Clinic of Barcelona","startDate":"2018-12-05","conditions":"Stroke, Acute","enrollment":121},{"nctId":"NCT03740958","phase":"PHASE4","title":"Argatroban Plus R-tPA for Acute Ischemic Stroke","status":"COMPLETED","sponsor":"General Hospital of Shenyang Military Region","startDate":"2018-12-21","conditions":"Stroke","enrollment":808},{"nctId":"NCT05172115","phase":"PHASE3","title":"Catheter-Directed Thrombolysis Versus Anticoagulation Monotherapy in Intermediate-High Risk PE","status":"TERMINATED","sponsor":"Rajaie Cardiovascular Medical and Research Center","startDate":"2018-12-22","conditions":"Pulmonary Embolism, Pulmonary Thromboembolisms, Embolism, Pulmonary","enrollment":94},{"nctId":"NCT04290494","phase":"","title":"Temporal Trends of Thrombolysis Treatment in Chinese Acute Ischemic Stroke (AIS) Patients From 2007-2017: Analysis of China National Stroke Registry (CNSR) I, II, and III; CTP-Draft Review Performed;","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2020-09-21","conditions":"Stroke","enrollment":42188},{"nctId":"NCT01422616","phase":"PHASE3","title":"Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED)","status":"COMPLETED","sponsor":"The George Institute","startDate":"2012-03","conditions":"Ischemic Stroke, High Blood Pressure","enrollment":4587},{"nctId":"NCT03803007","phase":"PHASE1, PHASE2","title":"Acute Ischemic Stroke Interventional Study","status":"COMPLETED","sponsor":"Acticor Biotech","startDate":"2019-03-06","conditions":"Acute Ischemic Stroke","enrollment":160},{"nctId":"NCT03394950","phase":"PHASE4","title":"Butyphthalide in Combination With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Hui-Sheng Chen","startDate":"2018-05-25","conditions":"Stroke, Ischemic","enrollment":120},{"nctId":"NCT03108833","phase":"PHASE2","title":"A Trial in Recombinant Human Prourokinase to Treat Acute Pulmonary Embolism","status":"COMPLETED","sponsor":"Tasly Biopharmaceuticals Co., Ltd.","startDate":"2017-06-06","conditions":"Acute Pulmonary Embolism","enrollment":108},{"nctId":"NCT04676659","phase":"PHASE2","title":"Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events(TRACE)","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2018-05-12","conditions":"Acute Ischemic Stroke","enrollment":240},{"nctId":"NCT03966079","phase":"PHASE3","title":"Thrombolysis Endovascular Treatment of Pulmonary Embolism","status":"COMPLETED","sponsor":"Beijing Tsinghua Chang Gung Hospital","startDate":"2017-01-01","conditions":"Pulmonary Embolism, Acute Pulmonary Embolism","enrollment":50},{"nctId":"NCT02893631","phase":"","title":"Assessment of Hemostasis Disorders in rtPA-treated Patients Requiring Endovascular Treatment for Ischemic Stroke","status":"COMPLETED","sponsor":"Fondation Ophtalmologique Adolphe de Rothschild","startDate":"2015-09","conditions":"Stroke, Acute","enrollment":120},{"nctId":"NCT01429350","phase":"PHASE4","title":"Assess the Penumbra System in the Treatment of Acute Stroke","status":"COMPLETED","sponsor":"Penumbra Inc.","startDate":"2012-05","conditions":"Ischemic Stroke","enrollment":108},{"nctId":"NCT04484558","phase":"","title":"Anxiety and Depression Disorder in Patient Treated With rTPA for Mangment of Acute Ischemic Stroke","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2020-01-01","conditions":"Acute Stroke, Anxiety Disorders, Depression","enrollment":40},{"nctId":"NCT02787278","phase":"PHASE2","title":"Safety and Efficacy of Two Doses of SP-8203 in Patients With Ischemic Stroke Requiring rtPA","status":"COMPLETED","sponsor":"Shin Poong Pharmaceutical Co. Ltd.","startDate":"2016-06-05","conditions":"Ischemic Stroke","enrollment":80},{"nctId":"NCT03886194","phase":"NA","title":"Thrombolytic and Interventional Treatment of Pulmonary Embolism","status":"UNKNOWN","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2019-08-18","conditions":"Pulmonary Embolism","enrollment":40},{"nctId":"NCT03158259","phase":"NA","title":"Prehospital Advanced Diagnostics and Treatment of Acute Stroke","status":"UNKNOWN","sponsor":"Norwegian Air Ambulance Foundation","startDate":"2017-05-15","conditions":"Ischemic (Brain) Stroke, Hemorrhagic Stroke, TIA, Brain","enrollment":400},{"nctId":"NCT02854592","phase":"","title":"Intravenous Thrombolysis Registry for Chinese Ischemic Stroke Within 4.5 h Onset","status":"COMPLETED","sponsor":"General Hospital of Shenyang Military Region","startDate":"2017-04-01","conditions":"Ischemic Stroke","enrollment":4000},{"nctId":"NCT04177615","phase":"NA","title":"Randomized Assessment of Rapid Endovascular Treatment in Basilar Artery Occlusion Stroke in 115 Hospital","status":"UNKNOWN","sponsor":"University of Medicine and Pharmacy at Ho Chi Minh City","startDate":"2019-11-19","conditions":"Stroke, Acute, Basilar Artery Occlusion","enrollment":109},{"nctId":"NCT04110275","phase":"PHASE2","title":"Injection of Recombinant Human Tissue-type Plasminogen Activator Derivative for Acute Pulmonary Embolism(rPA)","status":"UNKNOWN","sponsor":"Angde Biotech Pharmaceutical Co., Ltd.","startDate":"2019-10","conditions":"Acute Pulmonary Embolism","enrollment":174},{"nctId":"NCT01092819","phase":"","title":"A Clinical Trial to Assess the Acute Safety and Functional Outcome and Recovery After STROKE: The FIRST Trial","status":"COMPLETED","sponsor":"Penumbra Inc.","startDate":"2012-12","conditions":"Stroke","enrollment":150},{"nctId":"NCT03452722","phase":"","title":"Neuroinflammatory Response in Patients With ICH and IVH Treated With rtPA","status":"COMPLETED","sponsor":"University of Rijeka","startDate":"2011-06-01","conditions":"Hypertensive Intracerebral Hemorrhage, Intraventricular Hemorrhage, Brain Injuries","enrollment":88},{"nctId":"NCT03847883","phase":"PHASE4","title":"Low-dose Versus Standard Dose Alteplase in Acute Ischemic Stroke , 4 Monthes Prospective Study","status":"COMPLETED","sponsor":"Department of Medical Services Ministry of Public Health of Thailand","startDate":"2011-01-01","conditions":"Acute Stroke","enrollment":408},{"nctId":"NCT03506009","phase":"PHASE4","title":"Argatroban Plus r-tPA for Posterior Circulation Infarction（AR-PCI）","status":"TERMINATED","sponsor":"Hui-Sheng Chen","startDate":"2018-07-11","conditions":"Argatroban, Rt-PA","enrollment":3},{"nctId":"NCT01197573","phase":"NA","title":"Enhancing Donated After Cardiac Death (DCD) Utilization With Thrombolytic Therapy","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2010-04","conditions":"Liver Transplantation, Kidney Transplantation","enrollment":103},{"nctId":"NCT01472926","phase":"PHASE2","title":"Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis- (ATTEST)","status":"COMPLETED","sponsor":"NHS Greater Glasgow and Clyde","startDate":"2011-12","conditions":"Stroke","enrollment":104},{"nctId":"NCT01874093","phase":"PHASE3","title":"IMPACT- 24Bt Post Mech. Thrombectomy and/or rtPA TRIAL IMPlant Augmenting Cerebral Blood Flow 24 Hours From Stroke Onset","status":"TERMINATED","sponsor":"BrainsGate","startDate":"2013-05","conditions":"Ischemic Stroke","enrollment":27},{"nctId":"NCT03451903","phase":"","title":"Which Factors Influence the Duration and the Success of Mechanical Thrombectomy During the Acute Phase of Cerebral Infarction?","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"2015-01-01","conditions":"Acute Stroke","enrollment":106},{"nctId":"NCT03231384","phase":"NA","title":"Rt-PA Thrombolytic Therapy in Combination With Remote Ischemic Conditioning for Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Capital Medical University","startDate":"2017-08-10","conditions":"Ischemic Stroke","enrollment":31},{"nctId":"NCT02355743","phase":"PHASE4","title":"rtPA in in the Prevention of CVAD-Associated Thrombosis and Infection in Pediatric Patients With Short Bowel Syndrome","status":"COMPLETED","sponsor":"Lynn Malec","startDate":"2015-02-01","conditions":"Short Bowel Syndrome","enrollment":8},{"nctId":"NCT03392792","phase":"NA","title":"Regisry of the Stroke Patients in Assiut University Hospital","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2018-12-30","conditions":"All Patients With Ischemic Cerebrovascular Stroke Aged ≥18 Years of Both Sex","enrollment":1},{"nctId":"NCT00055159","phase":"PHASE1","title":"Low-Dose rtPA to Treat Blood Clots in Major Arm or Neck Veins","status":"COMPLETED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2003-02-19","conditions":"Thrombosis","enrollment":50},{"nctId":"NCT01657461","phase":"NA","title":"Solitaire™ With the Intention For Thrombectomy as PRIMary Endovascular Treatment (SWIFT PRIME) Trial","status":"COMPLETED","sponsor":"Medtronic Neurovascular Clinical Affairs","startDate":"2012-12","conditions":"Acute Ischemic Stroke","enrollment":196},{"nctId":"NCT01869478","phase":"PHASE2","title":"Feasibility Study of IV Recombinant Tissue Plasminogen Activator (rtPA) vs. Primary Endovascular Therapy for Acute Ischemic Stroke","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2013-01","conditions":"Stroke, Ischemic Stroke","enrollment":1},{"nctId":"NCT00811538","phase":"","title":"Swiss Intravenous and Intra-arterial Thrombolysis for Treatment of Acute Ischemic Stroke Registry","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2007-12","conditions":"Ischemic Stroke","enrollment":1476},{"nctId":"NCT01692379","phase":"PHASE3","title":"Endovascular Revascularization With Solitaire Device Versus Best Medical Therapy in Anterior Circulation Stroke Within 8 Hours","status":"TERMINATED","sponsor":"Fundacio Ictus Malaltia Vascular","startDate":"2012-11","conditions":"Acute Stroke","enrollment":206},{"nctId":"NCT01745692","phase":"NA","title":"Pragmatic Ischaemic Stroke Thrombectomy Evaluation","status":"TERMINATED","sponsor":"NHS Greater Glasgow and Clyde","startDate":"2012-12","conditions":"Acute Ischaemic Stroke","enrollment":65},{"nctId":"NCT01133223","phase":"PHASE2","title":"Safety and Efficacy of the Penumbra™ System in Acute Middle Cerebral Artery (MCA) Stroke","status":"WITHDRAWN","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2010-05","conditions":"Stroke","enrollment":""},{"nctId":"NCT01678495","phase":"PHASE2","title":"Sonothrombolysis Potentiated by Microbubbles for Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2012-08","conditions":"Cerebrovascular Stroke","enrollment":24},{"nctId":"NCT00224770","phase":"PHASE2","title":"Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation","status":"COMPLETED","sponsor":"Daniel Hanley","startDate":"2005-08","conditions":"Intracerebral Hemorrhage","enrollment":141},{"nctId":"NCT00860366","phase":"PHASE2, PHASE3","title":"Efficacy Study of Combined Treatment With Uric Acid and rtPA in Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Angel Chamorro, MD","startDate":"2011-06","conditions":"Acute Ischemic Stroke","enrollment":421},{"nctId":"NCT00640367","phase":"PHASE3","title":"Intra-arterial Versus Systemic Thrombolysis for Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Niguarda Hospital","startDate":"2008-02","conditions":"Stroke, Cerebrovascular Accident","enrollment":350},{"nctId":"NCT00303420","phase":"PHASE4","title":"Alteplase for Blood Flow Restoration in Hemodialysis Catheters","status":"TERMINATED","sponsor":"University of Manitoba","startDate":"2004-09","conditions":"Thrombosis","enrollment":180},{"nctId":"NCT00604630","phase":"PHASE2, PHASE3","title":"Multicenter Efficacy Study of Recombinant Human Erythropoietin in Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Max-Planck-Institute of Experimental Medicine","startDate":"2003-01","conditions":"Infarction, Middle Cerebral Artery, Middle Cerebral Artery Stroke, Stroke, Acute","enrollment":522},{"nctId":"NCT00001713","phase":"PHASE1","title":"Treatment for Blood Clots in the Veins of the Legs","status":"COMPLETED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"1998-02","conditions":"Embolism, Thrombophlebitis","enrollment":20},{"nctId":"NCT00383773","phase":"NA","title":"Retinal Endo Vascular Surgery for Central Retinal Vein Occlusion","status":"UNKNOWN","sponsor":"Hadassah Medical Organization","startDate":"2006-10","conditions":"Central Retinal Vein Occlusion","enrollment":10}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"HAEMOGLOBIN DECREASED"},{"count":2,"reaction":"HAEMORRHAGE INTRACRANIAL"},{"count":1,"reaction":"APHASIA"},{"count":1,"reaction":"ARRHYTHMIA"},{"count":1,"reaction":"BRAIN OEDEMA"},{"count":1,"reaction":"CARDIAC ARREST"},{"count":1,"reaction":"CARDIAC FAILURE"},{"count":1,"reaction":"CAROTID ARTERIAL EMBOLUS"},{"count":1,"reaction":"COMA"},{"count":1,"reaction":"CONDITION AGGRAVATED"}],"_approvalHistory":[],"publicationCount":4673,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["alteplase"],"phase":"marketed","status":"active","brandName":"rtPA","genericName":"rtPA","companyName":"Hui-Sheng Chen","companyId":"hui-sheng-chen","modality":"Small molecule","firstApprovalDate":"","aiSummary":"rtPA is a tissue plasminogen activator that converts plasminogen to plasmin, directly dissolving fibrin clots through fibrinolysis. Used for Acute ischemic stroke (within 3–4.5 hours of symptom onset), Acute myocardial infarction, Pulmonary embolism.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}